Gene Therapy Market - Forecast(2024 - 2030)

Report Code: HCR 0215 Report Format: PDF + Excel
Gene therapy can be defined as the treatment of a disease by modifying, replacing, or supplementing a genetic combination that is absent or abnormal and is responsible for causing causing the disease. Gene therapy has emerged as one of the most sought after research objectives in order to cure incurable diseases. Globally increasing instances of HIV, Cancer and other difficult to cure diseases is driving the demand for gene therapy.

This report identifies the gene therapy market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to gene therapy market.

Gene Therapy Market

Globally, North America dominates the market for gene therapy in 2015 with highest market share due to higher research and development activities by pharmaceutical industry in the region. North America was followed by Asia-Pacific as the second largest regional market for gene therapy due to higher faster growing pharma industry which is investing heavily in research and development activities for advanced treatment. Asia-Pacific is also expected to remain the fastest growing regional segment during the period of study due to increasing presence of global giants from pharma industry in the region.

This report on gene therapy covers different type of gene therapy developments, applications of gene therapy in curing diseases and market size in various geographical regions.
  • The report covers also cover gene therapy market developments from the development phase perspective as follows: Phase I, Phase II, Phase III
  • On the basis of applications of gene therapy, this report also covers all the major applications of gene therapy in curing major diseases, some of the major diseases covered in this report are as follows: Oncology, Infectious Diseases, Genetic Disorders, Cardiovascular Disorders, Diabetes Mellitus, Neurological Disorders and Others
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for gene therapy in each of the region.

This report identifies all the major companies operating in the gene therapy market. Some of the major companies’ profiles in detail are as follows:
  • American Gene Technologies International
  • Applied Genetic Technologies Corporation
  • Asklepios BioPharmaceutical      
  • AnGes MG
  • Urigen Pharmaceuticals
1. Gene Therapy Market - Overview
1.1. Definitions and Scope
2. Gene Therapy Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Gene Therapy Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Gene Therapy Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Gene Therapy Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Gene Therapy Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Gene Therapy Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Gene Therapy Market – By Development Phase (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Phase I
8.3.2. Phase II
8.3.3. Phase III
9. Gene Therapy Market – By Applications (Market Size -$Million / $Billion)
9.1. Oncology 
9.2. Infectious Diseases 
9.3.  Genetic Disorders
9.4. Cardiovascular Disorders 
9.5. Diabetes Mellitus
9.6. Neurological Disorders
10. Gene Therapy - By Geography (Market Size -$Million / $Billion)
10.1. Gene Therapy Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Gene Therapy - South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Gene Therapy - Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Gene Therapy – APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
11. Gene Therapy Market - Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Gene Therapy Market – Industry / Segment Competition landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practises for companies
13. Gene Therapy Market – Key Company List by Country Premium
14. Gene Therapy Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. American Gene Technologies International 
14.3. Applied Genetic Technologies Corporation
14.4. Asklepios BioPharmaceutical 
14.5. AnGes MG 
14.6. Urigen Pharmaceuticals
14.7. BioSante Pharmaceuticals
14.8. Oxford BioMedica
14.9. Genzyme Corporation
14.10. ReGenX Biosciences
14.11. Sangamo BioSciences 
14.12. Company 11
14.13. Company 12
14.14. Company 13 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Gene Therapy Market -Appendix
15.1. Abbreviations
15.2. Sources
16. Gene Therapy Market -Methodology Premium
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends
List of Tables:

Table 1: Gene Therapy Market Overview 2021-2026
Table 2: Gene Therapy Market Leader Analysis 2018-2019 (US$)
Table 3: Gene Therapy Market Product Analysis 2018-2019 (US$)
Table 4: Gene Therapy Market End User Analysis 2018-2019 (US$)
Table 5: Gene Therapy Market Patent Analysis 2013-2018* (US$)
Table 6: Gene Therapy Market Financial Analysis 2018-2019 (US$)
Table 7: Gene Therapy Market Driver Analysis 2018-2019 (US$)
Table 8: Gene Therapy Market Challenges Analysis 2018-2019 (US$)
Table 9: Gene Therapy Market Constraint Analysis 2018-2019 (US$)
Table 10: Gene Therapy Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Gene Therapy Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Gene Therapy Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Gene Therapy Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Gene Therapy Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Gene Therapy Market Value Chain Analysis 2018-2019 (US$)
Table 16: Gene Therapy Market Pricing Analysis 2021-2026 (US$)
Table 17: Gene Therapy Market Opportunities Analysis 2021-2026 (US$)
Table 18: Gene Therapy Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Gene Therapy Market Supplier Analysis 2018-2019 (US$)
Table 20: Gene Therapy Market Distributor Analysis 2018-2019 (US$)
Table 21: Gene Therapy Market Trend Analysis 2018-2019 (US$)
Table 22: Gene Therapy Market Size 2018 (US$)
Table 23: Gene Therapy Market Forecast Analysis 2021-2026 (US$)
Table 24: Gene Therapy Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Gene Therapy Market, Revenue & Volume, By Development Phase, 2021-2026 ($)
Table 26: Gene Therapy Market By Development Phase, Revenue & Volume, By Phase I, 2021-2026 ($)
Table 27: Gene Therapy Market By Development Phase, Revenue & Volume, By Phase II, 2021-2026 ($)
Table 28: Gene Therapy Market By Development Phase, Revenue & Volume, By Phase III, 2021-2026 ($)
Table 29: Gene Therapy Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 30: Gene Therapy Market By Application, Revenue & Volume, By Oncology, 2021-2026 ($)
Table 31: Gene Therapy Market By Application, Revenue & Volume, By Infectious Diseases, 2021-2026 ($)
Table 32: Gene Therapy Market By Application, Revenue & Volume, By Genetic Disorders, 2021-2026 ($)
Table 33: Gene Therapy Market By Application, Revenue & Volume, By Cardiovascular Disorders, 2021-2026 ($)
Table 34: Gene Therapy Market By Application, Revenue & Volume, By Diabetes Mellitus, 2021-2026 ($)
Table 35: North America Gene Therapy Market, Revenue & Volume, By Development Phase, 2021-2026 ($)
Table 36: North America Gene Therapy Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 37: South america Gene Therapy Market, Revenue & Volume, By Development Phase, 2021-2026 ($)
Table 38: South america Gene Therapy Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 39: Europe Gene Therapy Market, Revenue & Volume, By Development Phase, 2021-2026 ($)
Table 40: Europe Gene Therapy Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 41: APAC Gene Therapy Market, Revenue & Volume, By Development Phase, 2021-2026 ($)
Table 42: APAC Gene Therapy Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 43: Middle East & Africa Gene Therapy Market, Revenue & Volume, By Development Phase, 2021-2026 ($)
Table 44: Middle East & Africa Gene Therapy Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 45: Russia Gene Therapy Market, Revenue & Volume, By Development Phase, 2021-2026 ($)
Table 46: Russia Gene Therapy Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 47: Israel Gene Therapy Market, Revenue & Volume, By Development Phase, 2021-2026 ($)
Table 48: Israel Gene Therapy Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 49: Top Companies 2018 (US$)Gene Therapy Market, Revenue & Volume
Table 50: Product Launch 2018-2019Gene Therapy Market, Revenue & Volume
Table 51: Mergers & Acquistions 2018-2019Gene Therapy Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Gene Therapy Market 2021-2026
Figure 2: Market Share Analysis for Gene Therapy Market 2018 (US$)
Figure 3: Product Comparison in Gene Therapy Market 2018-2019 (US$)
Figure 4: End User Profile for Gene Therapy Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Gene Therapy Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Gene Therapy Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Gene Therapy Market 2018-2019
Figure 8: Ecosystem Analysis in Gene Therapy Market 2018
Figure 9: Average Selling Price in Gene Therapy Market 2021-2026
Figure 10: Top Opportunites in Gene Therapy Market 2018-2019
Figure 11: Market Life Cycle Analysis in Gene Therapy Market
Figure 12: Global By Development PhaseGene Therapy Market Revenue, 2021-2026 ($)
Figure 13: GlobalBy ApplicationGene Therapy Market Revenue, 2021-2026 ($)
Figure 14: Global Gene Therapy Market - By Geography
Figure 15: Global Gene Therapy Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 16: Global Gene Therapy Market CAGR, By Geography, 2021-2026 (%)
Figure 17: North America Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 18: US Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 31: Brazil Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 60: U.K Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 93: China Gene Therapy Market Value & Volume, 2021-2026
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Gene Therapy Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Gene Therapy Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 122: Russia Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Gene Therapy Market Value & Volume, 2021-2026 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Gene Therapy Market
Figure 131: Developments, 2018-2019*Gene Therapy Market
Figure 132: Company 1 Gene Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Gene Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Gene Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Gene Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Gene Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Gene Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3 Gene Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3 Gene Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3 Gene Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Gene Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Gene Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Gene Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Gene Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Gene Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Gene Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Gene Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Gene Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Gene Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Gene Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Gene Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Gene Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Gene Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Gene Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Gene Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Gene Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Gene Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Gene Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Gene Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Gene Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Gene Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Gene Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Gene Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Gene Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Gene Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Gene Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Gene Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13 Gene Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13 Gene Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13 Gene Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Gene Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Gene Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Gene Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Gene Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Gene Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Gene Therapy Market Net Sales Share, By Geography, 2018 (%)